Overview
Ira Schwartz is a primary care provider, practicing in Internal Medicine in Portsmouth, New Hampshire. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and Sitosterolemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- EPO
- MANAGED MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Borthwick Ave, Suite 308, Portsmouth, NH 03801
Beth Israel Deaconess Medical Center - Hematology/Oncology
Jon Arnason is an Internal Medicine provider in Boston, Massachusetts. Dr. Arnason is rated as an Elite provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Appledore Medical Group Inc.
Maureen Gallagher is a primary care provider, practicing in Internal Medicine in Hampton, New Hampshire. Dr. Gallagher is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. Her top areas of expertise are Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Down Syndrome.
Foundation Medical Partners Inc
Peter Lundquist is a primary care provider, practicing in Internal Medicine in Nashua, New Hampshire. Dr. Lundquist is rated as an Advanced provider by MediFind in the treatment of Richter Syndrome. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), and Peripheral Artery Disease.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial HypertensionDr. Schwartz isDistinguished. Learn about Familial Hypertension.
- Glucocorticoid-Remediable AldosteronismDr. Schwartz isDistinguished. Learn about Glucocorticoid-Remediable Aldosteronism.
- HypertensionDr. Schwartz isDistinguished. Learn about Hypertension.
- SitosterolemiaDr. Schwartz isDistinguished. Learn about Sitosterolemia.
- Advanced
- Congenital Sucrase-Isomaltase Deficiency
- Foot DropDr. Schwartz isAdvanced. Learn about Foot Drop.
- Gastroesophageal Reflux Disease (GERD)
- Glucose Phosphate Isomerase Deficiency
- Glucose-Galactose Malabsorption Deficiency
- High CholesterolDr. Schwartz isAdvanced. Learn about High Cholesterol.
- Experienced
- Acquired Amegakaryocytic ThrombocytopeniaDr. Schwartz isExperienced. Learn about Acquired Amegakaryocytic Thrombocytopenia.
- Acrogeria, Gottron TypeDr. Schwartz isExperienced. Learn about Acrogeria, Gottron Type.
- Acute Kidney FailureDr. Schwartz isExperienced. Learn about Acute Kidney Failure.
- Acute Mountain SicknessDr. Schwartz isExperienced. Learn about Acute Mountain Sickness.
- Addison's DiseaseDr. Schwartz isExperienced. Learn about Addison's Disease.
- ALK-Positive Non-Small Cell Lung CancerDr. Schwartz isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.